Foghorn therapeutics to participate in the citizens life sciences conference

Cambridge, mass., may 05, 2025 (globe newswire) -- foghorn® therapeutics inc. (nasdaq: fhtx), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that management will participate in the citizens life sciences conference, being held may 7-8, 2025, in new york, ny.
FHTX Ratings Summary
FHTX Quant Ranking